MyD88 in myeloid cells drives angiotensin II-induced vascular inflammation, is associated with prevalent heart failure, and predicts all-cause mortality in arterial hypertension

European Heart Journal Open · Published 2026-02-25 · DOI 10.1093/ehjopen/oeag031

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1093/ehjopen/oeag031

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• The Adventitia, Vascular Inflammation, and the Intersection of Hypertension and Vascular Disease · Atherosclerosis · 2026 · Cites or is cited by this article
• Cilostazol for heart rate increase in atrial fibrillation with slow ventricular response: an exploratory randomized controlled trial · European Heart Journal Open · 2026 · Same journal
• Finerenone vs. spironolactone to reduce adverse outcomes in patients with cardiac–kidney–metabolic syndrome complicated by atrial fibrillation: findings from the Tianjin atrial fibrillation project · European Heart Journal Open · 2026 · Same journal
• Risk factors for cardiac death in women with coronary artery disease · European Heart Journal Open · 2026 · Same journal
• Cardiac autonomic function in elderly patients with and without atrial fibrillation · European Heart Journal Open · 2026 · Same journal
• Left bundle branch area pacing: anatomical and physiological features made easy · European Heart Journal Open · 2026 · Same journal
• From simulator to patient: transfer of procedural skills to practice in cardiac device implantation · European Heart Journal Open · 2026 · Same journal
• Asymptomatic and symptomatic cardiac toxicity associated with immune checkpoint inhibitors: insights from a Japanese registry · European Heart Journal Open · 2026 · Same journal
• Angiotensin-converting enzyme inhibitors show an edge over angiotensin II receptor blockers in cardiovascular outcomes · European Heart Journal Open · 2026 · Same journal
• Impact of chronic kidney disease on clinical outcomes among patients with atrial fibrillation following percutaneous left atrial appendage occlusion: a multicentre cohort study · European Heart Journal Open · 2026 · Same journal